Skip to main content

Table 1 Clinical characteristics at the begining and at the study end (N = 51)

From: Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus

 

Baseline

12-weeks after

P

Waist circumference (cm)

103.3 (12.3)

101.4 (11.8)

0.012

24 h SBP (mmHg)

125.74 (13.41)

123.54 (10.87)

<0.001

24 h DBP (mmHg)

74.49 (7.59)

73.67 (7.45)

0.281

HbA1c (%)

6.9 (1.1)

6.9 (0.7)

0.461

Cholesterol (mmol/L)

5.18 (1.0)

4.62 (1.60)

0.001

HDL-C (mmol/L)

1.29 (0.24)

1.31 (0.23)

0.973

LDL-C (mmol/L)

2.89 (0.84)

2.54 (0.85)

0.005

Triglycerides (mmol/L)

2.26 (1.35)

1.81 (0.91)

0.001

hsCRP (mg/L)

3.21 (0.86)

1.95 (1.59)

0.009

  1. Data are expressed as mean (SD), HbA1c gycated haemoglobin, Chol cholesterol, HDL-C high density cholesterol, LDL-C low density cholesterol, Tgc triglycerides, hsCRP high sensitive C-reactive protein